Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial (Q36689416)
Jump to navigation
Jump to search
scientific article published on 10 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial |
scientific article published on 10 December 2015 |
Statements
1 reference
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial (English)
1 reference
Patricia A Ganz
1 reference
Eleftherios P Mamounas
1 reference
Richard G Margolese
1 reference
Thomas B Julian
1 reference
Joseph P Costantino
1 reference
Laura A Vallow
1 reference
Kathy S Albain
1 reference
Patrick W Whitworth
1 reference
Mary E Cianfrocca
1 reference
Adam M Brufsky
1 reference
Howard M Gross
1 reference
Gamini S Soori
1 reference
Judith O Hopkins
1 reference
Louis Fehrenbacher
1 reference
Keren Sturtz
1 reference
Timothy F Wozniak
1 reference
Thomas E Seay
1 reference
Norman Wolmark
1 reference
10 December 2015
1 reference
1 reference
10021
1 reference
849-856
1 reference
Identifiers
1 reference
1 reference
1 reference